ISPOR Strategic Plan 2030


Prologue

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) is the largest and most influential organization in the world focused on the field of HEOR. Since 1995, the Society has advanced the science, policy, and practice of both health economics (the study of the behavior of individuals, healthcare providers, public and private organizations, and governments in decision making) and outcomes research (the evaluation of healthcare interventions on patient well-being, including clinical, economic, and patient-centered outcomes). During this time, the scope and sphere of influence of ISPOR has grown to comprise virtually every key stakeholder in the healthcare ecosystem, including health economists, outcomes researchers, academicians, health technology developers and assessors, regulators, industry leaders, healthcare policy makers, payers, providers, and crucially, patients. This multistakeholder perspective is foundational to ISPOR’s continuing ability to increase the understanding and application of HEOR to improve healthcare decisions. As a global resource of unbiased information and a catalyst for innovation in the HEOR field, the Society’s membership comprises more than 17,000 individual and chapter members from 100+ countries worldwide.


Strategic Plan 2030 MVV Icon

Our Vision


A world where healthcare is accessible, effective, efficient, and affordable for all

Strategic Plan 2030 MVV - Vision Only

Our Mission


To advance health economics and outcomes research excellence to improve decision making for health globally

Strategic Plan 2030 MVV - Mission Only

Our Values


Transformative | Scientific | Inclusive | Collaborative | Transparent | Ethical

Strategic Plan 2030 MVV - Values Only


ISPOR's Core Values

In all that ISPOR does, the Society is guided by a set of core values that underpin every decision and action. These values can be described as the deeply ingrained principles that guide our actions; they are ISPOR’s cultural cornerstones. Management scholars Jim Collins and Jerry Poras define core values as being inherent and sacrosanct; they can never be compromised, either for convenience or short-term economic gain.

ISPOR’s core values are:

Transformative
We are unafraid to take a bold and visionary approach to value in health, leading healthcare decision making in adapting to the evolving landscape.

Scientific
We are data-driven and rigorous in our approach to support informed, evidence-based healthcare decision making.

Inclusive
We actively engage with a diverse and global group of stakeholders to foster an environment
where all perspectives are heard and valued.

Collaborative
We proactively collaborate with partners with an understanding that expertise might lie both within and outside of ISPOR.

Transparent
We are committed to being open, honest, and clear in all aspects of our operations to enable trust amongst members and partners.

Ethical
We conduct ourselves with integrity and hold ourselves to the ISPOR code of conduct.



"These values can be described as the deeply ingrained principles that guide our actions; they are ISPOR’s cultural cornerstones."
 

A Vision For the Road Ahead

As ISPOR emerged from the long shadow of the COVID-19 pandemic, new CEO Rob Abbott and President Brian O'Rourke felt the time was right to forge a new strategy for the Society. They both expressed a desire to see ISPOR leverage its experience and expertise in HEOR, as well as its global profile and reputation, to contribute meaningfully to the biggest challenges in healthcare:

1. Affordability and its impact on the long-term sustainability of healthcare systems

2. Digital Health and its influence on the transformation of healthcare

3. Whole Health and its potential to improve the wellbeing of people across the globe

It is critical that HEOR—and by association, ISPOR—anticipate the needs of a rapidly changing healthcare environment and position itself to ensure relevance and impact. In the face of increasing demands for healthcare globally combined with constrained resources to meet those demands, the importance of leveraging HEOR to inform healthcare decision making has never been greater.




"In the face of increasing demands for healthcare globally combined with constrained resources to meet those demands, the importance of leveraging HEOR to inform healthcare decisions making has never been greater."
 

The Aspiration to Lead Global Change in Health Policy

An overarching aspiration in the strategy that emerged from deliberating on the past, present, and possible future of HEOR, and the major drivers of healthcare change, was to position ISPOR not merely as a respected organization but as the trusted global HEOR advisor leading change in health policy. To do so, it was necessary to consider where and how HEOR had “moved the needle” in the design and delivery of healthcare and equally, where it had not. The Society’s Health Science Policy Council therefore authored a visioning article that revealed several important findings:

1. HEOR information, while scientifically rigorous, was not consistently relevant or appropriate for healthcare policy or decision makers.

2. HEOR information that might otherwise be useful was not available at the time healthcare decisions were made.

3. The complexity of HEOR information was not seen to be transparent and therefore not trusted by decision makers and/or their constituents.

4. There is a lack of training in HEOR and its use at the decision-maker level.

5. There are structural conditions embedded within the healthcare ecosystem that are not conducive to the use of HEOR information.

Addressing the first 3 of these barriers requires better understanding and anticipation of the needs of specific decision makers— such as payers, physicians, and patients—and dedication to generating and tailoring HEOR evidence that is useful to them. In particular, greater attention to validation of decision-analytic models’ predictions of long-term outcomes using real-world data (RWD) could lead to greater credibility. Further, improved outreach and engagement might improve decision-maker confidence in the HEOR information they receive. Greater focus on the use of HEOR principles in health policy formation can help to reduce structural barriers. In short, the metaphorical “finish line” for much of the work that ISPOR has championed has moved. It is no longer sufficient to curate great science; it is equally necessary to translate that science into plain language and present it to decision makers in a way that enhances understanding and use. The new ISPOR Strategic Plan 2030 reflects this reality.




"It is no longer sufficient to curate great science; it is equally necessary to translate that science into plain language and present it to decision makers in a way that enhances understanding and use."
 

A Note on the Term "Value" in an HEOR Context

Health economists and outcomes researchers often use the term “value” to speak about the benefit that a given healthcare intervention, such as a new drug therapy, may bring to stakeholders. When the term value is used in an HEOR context, HEOR professionals do not intend to suggest the concept of “cheap” or “low cost” (as this term may indicate when used in consumer marketing, for example).

The term value, when used in an HEOR context, is intended to convey the concept of bringing the best that medicine has to offer, to the largest number of people, at reasonable cost. Value used in the field of HEOR connotes that a given medical intervention actually works and will make a positive difference in the lives of patients. Value means that the pricing of the health intervention—whatever it may be—does not create insurmountable barriers for patients and their families.




“The term VALUE, when used in an HEOR context, is intended to convey the concept of bringing the best that medicine has to offer, to the largest number of people, at reasonable cost."
  

ISPOR's Goals

To realize ISPOR’s new vision—a world where healthcare is accessible, effective, efficient, and affordable for all—two simple, clear goals have been set to guide the future course of the Society’s efforts. With healthcare systems around the world struggling under the weight of rising costs and increasingly complex choices for decision makers, achieving these goals and advancing HEOR has never been more important.

The first goal speaks to ISPOR’s desire to build on the strong foundation of scientific research excellence that has long defined ISPOR and to extend it in such a manner that we are, and are seen to be, the world leaders in the definition, measurement, and use of value to improve healthcare decision making.

The second goal speaks to ISPOR’s intention to not only curate scientific and research excellence but to translate that scientific work and package it in such a way that it is used to make a real difference in the lives of patients worldwide as they access their healthcare system.




With healthcare systems around the world struggling under the weight of rising costs and increasingly complex choices for decision makers, achieving these goals and advancing HEOR has never been more important."
  

Executing ISPOR's Goals and Objectives

ISPOR recognizes that it is no small feat to advance the Society’s mission and to work collaboratively toward the vision of a world where healthcare is accessible, effective, efficient, and affordable for all. Executing the Society’s goals and objectives requires resources and an operational structure. ISPOR’s organizational approach and foundational elements are designed to enable these goals and objectives. Four core foundational elements support this purpose.




“ISPOR’s organizational approach and foundational elements are designed to enable these goals and objectives."
  

Multistakeholder Perspective

ISPOR's multistakeholder perspective is foundational to its continuing ability to increase the understanding and application of health economics and outcomes research (HEOR) to improve healthcare decisions.




“ISPOR’s multistakeholder perspective is foundational to its continuing ability to increase the understanding and application of health economics and outcomes research to improve healthcare decisions."

Acknowledgements

ISPOR's Strategic Plan 2030 was developed through the input and guidance from many of the Society’s leaders, including its board of directors, past presidents, council and other member group leaders, past board members, and others. Their significant contributions were vital to the development of this plan.

It is important to note the crucial role of ISPOR’s 2023–2024 Board of Directors who directed the work on this initiative. Special thanks to Dr Brian O’Rourke, the Society’s 2023-2024 President, who led the development and finalization of the plan.

ISPOR 2023–2024 Board of Directors

2023-2024 President
Brian O’Rourke, PharmD, CD, OMM

Brian O’Rourke Health Care Consulting, Inc

2023-2024 Immediate Past President
Jan Elias Hansen, PhD

Genentech

2023-2024 President-Elect
Eberechukwu Onukwugha, PhD

University of Maryland

Director
Dalia Dawoud, PhD

The National Institute for Health and Care Excellence (NICE)

Director
Beth Devine, PhD

University of Washington

Director
Marlene Gyldmark, MPhil

Idorsia Pharmaceuticals, Ltd

Director
Andrea Manca, MSc, PhD

University of York

Director
Lucinda Orsini, DPM, MPH

COMPASS Pathways

Director
Amy O’Sullivan, PhD

Ontada

Director
Dong-Churl Suh, PhD

Chung-Ang University College of Pharmacy

Director
Sean D. Sullivan, BScPharm, MSc, PhD

University of Washington

CEO and Executive Director
Rob Abbott
ISPOR—The Professional Society for Health Economics and Outcomes Research



“ISPOR’s Strategic Plan 2030 was developed through the input and guidance from many of the Society’s leaders, including its board of directors, past presidents, council and other member group leaders, past board members, and others."
  

 

 

 

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×